HEMAREG Trademark

Trademark Overview

On Saturday, June 19, 2010, a trademark application was filed for HEMAREG with the United States Patent and Trademark Office. The USPTO has given the HEMAREG trademark a serial number of 79087260. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, June 19, 2020. This trademark is owned by Affymax Pharma Limited. The HEMAREG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
hemareg

General Information

Serial Number79087260
Word MarkHEMAREG
Filing DateSaturday, June 19, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, June 19, 2020
Registration Number4030496
Registration DateTuesday, September 27, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2011

Trademark Statements

Goods and ServicesPharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffymax Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB
Party NameAffymax Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB
Party NameAffymax Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB

Trademark Events

Event DateEvent Description
Saturday, July 10, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, July 10, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, March 8, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, January 17, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, January 17, 2019INVALIDATION PROCESSED
Friday, January 4, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 4, 2018CANCELLED SECTION 71
Tuesday, September 27, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, August 4, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 23, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 30, 2012FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 30, 2012FINAL DISPOSITION PROCESSED
Tuesday, December 27, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 27, 2011REGISTERED-PRINCIPAL REGISTER
Sunday, September 4, 2011NOTIFICATION PROCESSED BY IB
Tuesday, July 12, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2011PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 22, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 8, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 8, 2011ASSIGNED TO LIE
Tuesday, May 24, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2011ASSIGNED TO EXAMINER
Thursday, April 21, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 20, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 20, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 2, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 10, 2010REFUSAL PROCESSED BY IB
Thursday, October 21, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 21, 2010REFUSAL PROCESSED BY MPU
Thursday, October 21, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 20, 2010NON-FINAL ACTION WRITTEN
Tuesday, October 19, 2010APPLICATION FILING RECEIPT MAILED
Friday, October 15, 2010ASSIGNED TO EXAMINER
Friday, October 15, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 14, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

hemareg failure pharmaceuticals cellular induced degeneration heart stroke hypoxia renal congestive